Table 2.
Laboratory measurements of T2DM participants in the sarcopenia group and control group stratified by sex.
| Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
| Control group | Sarcopenia group | t | P | Control group | Sarcopenia group | t | P | |
| FPG (mmol/l) | 7.6 ± 2.4 | 8.5 ± 2.7 | -3.352 | 0.001 | 7.7 ± 2.7 | 8.8 ± 3.1 | -2.660 | 0.008 |
| HbA1c (%) | 6.9 ± 1.5 | 7.8 ± 1.7 | -6.552 | ≤0.001 | 7.4 ± 1.9 | 8.2 ± 2.0 | -3.151 | 0.002 |
| Red blood cells (1012/l) | 4.8 ± 0.4 | 4.5 ± 0.5 | 6.207 | ≤0.001 | 4.4 ± 0.4 | 4.3 ± 0.4 | 0.700 | 0.484 |
| Hemoglobin (g/l) | 147.7 ± 13.8 | 138.7 ± 14.1 | 7.734 | ≤0.001 | 130.8 ± 12.7 | 130.7 ± 12.4 | 0.053 | 0.958 |
| Hematocrit (%) | 43 ± 4.7 | 40.3 ± 4.2 | 7.062 | ≤0.001 | 38.9 ± 3.7 | 38.9 ± 3.8 | 0.004 | 0.997 |
| Albumin (g/l) | 43.9 ± 4.2 | 41.0 ± 3.3 | 9.133 | ≤0.001 | 42.9 ± 3.9 | 42.9 ± 3.9 | -0.104 | 0.917 |
| Creatinine (μmol/l) | 71.4 ± 13 | 71.1 ± 18.6 | 0.222 | 0.824 | 55.6 ± 13.4 | 59 ± 16.2 | -2.315 | 0.021 |
| eGFR (ml/min) | 109.6 ± 30.1 | 101.8 ± 31.1 | 3.092 | 0.002 | 101.7 ± 28.1 | 89.1 ± 29.1 | 4.162 | ≤0.001 |
Notes: data were expressed as the mean ± standard deviation or % and median (25th–75th percentile). Abbreviations: FPG: fasting plasma glucose; HbA1c: glycated hemoglobin; eGFR: estimated glomerular filtration rate; TG: triglycerides; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.